2025-08 Stock Rater test 2

Asset Allocation

Position	Category/Sector	Target Weight
CAT Caterpillar Inc.	Industrials	5.26%
MS Morgan Stanley	Financial Services	5.26%
ABBV AbbVie Inc.	Healthcare	5.26%
GLW Corning Incorporated	Technology	5.26%
CVS CVS Health Corporation	Healthcare	5.26%
MRK Merck & Co., Inc.	Healthcare	5.26%
RTX RTX Corporation	Industrials	5.26%
AMZN Amazon.com, Inc	Consumer Cyclical	5.26%
ADBE Adobe Inc	Technology	5.26%
SUI Sun Communities, Inc.	Real Estate	5.26%
ZS Zscaler, Inc.	Technology	5.26%
AMGN Amgen Inc.	Healthcare	5.26%
LOW Lowe's Companies, Inc.	Consumer Cyclical	5.26%
TMO Thermo Fisher Scientific Inc.	Healthcare	5.26%
JPM JPMorgan Chase & Co.	Financial Services	5.26%
NEE NextEra Energy, Inc.	Utilities	5.26%
BNS The Bank of Nova Scotia	Financial Services	5.26%
ABT Abbott Laboratories	Healthcare	5.26%
VZ Verizon Communications Inc.	Communication Services	5.26%

Benchmark Against

Benchmark

S&P 500 Index

Rebalance

Portfolio Optimizer

Find the right asset allocation for 2025-08 Stock Rater test 2

Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in 2025-08 Stock Rater test 2, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Loading charts...

Returns By Period

Position	1D	1M	YTD	6M	1Y	3Y*	5Y*	10Y*
Benchmark S&P 500 Index	0.50%	0.31%	8.56%	8.85%	24.33%	19.37%	11.84%	13.61%
Portfolio 2025-08 Stock Rater test 2	0.38%	1.14%	7.20%	7.60%	28.57%	20.07%	12.21%	—
Portfolio components:
ABBV AbbVie Inc.	1.32%	8.24%	1.30%	3.65%	23.06%	22.39%	18.94%	19.10%
ABT Abbott Laboratories	-1.64%	4.39%	-28.82%	-28.92%	-33.65%	-2.76%	-2.50%	10.94%
ADBE Adobe Inc	-6.76%	-17.60%	-41.71%	-42.76%	-47.91%	-24.76%	-17.73%	7.72%
AMGN Amgen Inc.	0.32%	8.85%	10.10%	13.41%	23.93%	20.61%	11.36%	12.08%
AMZN Amazon.com, Inc	-1.23%	-9.69%	3.35%	5.46%	12.47%	23.49%	7.35%	20.83%
BNS The Bank of Nova Scotia	1.57%	8.96%	16.52%	17.99%	62.38%	27.10%	11.56%	11.61%
CAT Caterpillar Inc.	1.44%	2.51%	59.62%	52.94%	157.79%	57.16%	35.17%	31.33%
CVS CVS Health Corporation	1.47%	6.33%	30.67%	30.57%	56.67%	16.60%	7.08%	3.70%
GLW Corning Incorporated	1.50%	-6.43%	105.36%	103.59%	265.24%	79.90%	36.42%	27.57%
JPM JPMorgan Chase & Co.	2.31%	7.69%	0.50%	1.66%	23.40%	34.22%	17.82%	21.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 16, 2018, 2025-08 Stock Rater test 2's average daily return is +0.07%, while the average monthly return is +1.38%. At this rate, an investment would double in approximately 4.2 years.

Historically, 68% of months were positive and 32% were negative. The best month was Nov 2020 with a return of +11.3%, while the worst month was Mar 2020 at -8.0%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 3 months.

On a daily basis, 2025-08 Stock Rater test 2 closed higher 56% of trading days. The best single day was Mar 13, 2020 with a return of +9.0%, while the worst single day was Mar 16, 2020 at -11.3%.

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total
2026	2.36%	4.03%	-5.78%	5.01%	1.45%	0.30%							7.20%
2025	7.40%	0.79%	-3.49%	-2.39%	4.91%	4.10%	2.47%	4.47%	4.07%	3.75%	1.86%	-0.08%	31.02%
2024	2.74%	2.34%	2.91%	-5.39%	3.00%	1.62%	4.18%	3.59%	1.36%	-1.54%	3.93%	-6.60%	12.03%
2023	4.53%	-3.94%	0.25%	-0.39%	-1.92%	6.67%	3.25%	-1.95%	-4.60%	-2.86%	8.45%	7.46%	14.72%
2022	-3.08%	-2.48%	1.13%	-7.41%	2.18%	-6.50%	5.80%	-3.99%	-7.97%	7.57%	6.78%	-3.60%	-12.48%
2021	0.33%	1.90%	4.54%	3.63%	1.83%	1.26%	2.45%	3.41%	-4.56%	7.46%	-1.74%	4.97%	28.00%

Benchmark Metrics

2025-08 Stock Rater test 2 has an annualized alpha of 5.12%, beta of 0.86, and R2 of 0.87 versus S&P 500 Index. Calculated based on daily prices since March 16, 2018.

This portfolio captured 101.40% of S&P 500 Index gains but only 86.68% of its losses - a favorable profile for investors.
This portfolio generated an annualized alpha of 5.12% versus S&P 500 Index - delivering returns beyond what market exposure alone would predict.
With beta of 0.86 and R2 of 0.87, this portfolio moves broadly in line with S&P 500 Index - much of its variation is explained by market exposure rather than independent behavior.

Alpha: 5.12%

Beta: 0.86

R²: 0.87

Upside Capture: 101.40%

Downside Capture: 86.68%

See how alpha, beta & R² have trended over time →

Expense Ratio

2025-08 Stock Rater test 2 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

2025-08 Stock Rater test 2 ranks 72 for risk / return — better than 72% of Portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

Overall Rank

Sharpe Ratio Rank

Sortino Ratio Rank

Omega Ratio Rank

Calmar Ratio Rank

Martin Ratio Rank

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below presents risk-adjusted performance metrics for 2025-08 Stock Rater test 2 and compares them with S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	Portfolio	Benchmark	Difference
Sharpe ratioReturn per unit of total volatility	2.29	1.86	+0.43
Sortino ratioReturn per unit of downside risk	3.31	2.53	+0.77
Omega ratioGain probability vs. loss probability	1.41	1.34	+0.07
Calmar ratioReturn relative to maximum drawdown	3.35	2.53	+0.82
Martin ratioReturn relative to average drawdown	13.44	11.37	+2.07

How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Position	Risk / Return Rank	Sharpe ratio	Sortino ratio	Omega ratio	Calmar ratio	Martin ratio
ABBV AbbVie Inc.	67	0.92	1.42	1.18	1.29	2.88
ABT Abbott Laboratories	3	-1.40	-1.92	0.75	-0.88	-1.92
ADBE Adobe Inc	1	-1.45	-2.33	0.73	-1.03	-1.99
AMGN Amgen Inc.	67	0.84	1.42	1.17	1.40	3.22
AMZN Amazon.com, Inc	53	0.40	0.76	1.09	0.55	1.29
BNS The Bank of Nova Scotia	96	3.73	5.22	1.68	4.69	18.38
CAT Caterpillar Inc.	98	4.43	5.03	1.65	11.24	36.80
CVS CVS Health Corporation	86	1.92	2.33	1.35	3.62	9.33
GLW Corning Incorporated	98	4.59	4.25	1.60	11.23	35.65
JPM JPMorgan Chase & Co.	69	1.01	1.43	1.18	1.42	3.36

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk. Learn how to interpret the Sharpe ratio.

The current 2025-08 Stock Rater test 2 Sharpe ratio is 2.29 as of Jun 13, 2026 (the value is recalculated daily), calculated over the past 12 months.

Compared to the broad market, where average Sharpe ratios range from 1.53 to 2.41, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of 2025-08 Stock Rater test 2 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Loading charts...

Dividends

Dividend yield

2025-08 Stock Rater test 2 provided a 2.03% dividend yield over the last twelve months.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Portfolio	2.03%	2.33%	2.59%	2.74%	2.44%	2.08%	3.15%	2.08%	2.36%	2.08%	2.32%	2.51%
Portfolio components:
ABBV AbbVie Inc.	2.96%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
ABT Abbott Laboratories	2.77%	1.88%	1.95%	1.85%	1.71%	1.28%	1.32%	1.47%	1.55%	1.86%	2.71%	2.14%
ADBE Adobe Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
AMGN Amgen Inc.	2.76%	2.91%	3.45%	2.96%	2.95%	3.13%	2.78%	2.41%	2.71%	2.65%	2.74%	1.95%
AMZN Amazon.com, Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
BNS The Bank of Nova Scotia	3.79%	4.17%	5.85%	8.56%	6.39%	5.09%	4.93%	3.53%	6.34%	4.80%	5.24%	8.13%
CAT Caterpillar Inc.	0.66%	1.02%	1.49%	1.69%	1.93%	2.07%	2.26%	2.56%	2.58%	1.97%	3.32%	4.33%
CVS CVS Health Corporation	2.61%	3.35%	5.93%	3.06%	2.36%	1.94%	2.93%	2.69%	3.05%	2.76%	2.15%	1.43%
GLW Corning Incorporated	0.63%	1.28%	2.36%	3.68%	3.38%	2.58%	2.44%	2.75%	2.38%	1.94%	2.22%	2.63%
JPM JPMorgan Chase & Co.	1.84%	1.72%	1.92%	2.38%	2.98%	2.34%	2.83%	2.37%	2.54%	1.91%	2.13%	2.54%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the 2025-08 Stock Rater test 2. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 2025-08 Stock Rater test 2 was 30.08%, occurring on Mar 23, 2020. Recovery took 52 trading sessions.

The current 2025-08 Stock Rater test 2 drawdown is 1.35%.

Related event	Drawdown	Fall	Recovery	Underwater
COVID crash2020	-30.08%Mar 2020	1mo 2d	2mo 14d	3mo 16dFeb 2020 - Jun 2020
Bear market2022	-21.12%Oct 2022	9mo 15d	1y 2mo	1y 12moDec 2021 - Dec 2023
Rate-hike selloffLate 2018	-15.41%Dec 2018	2mo 23d	2mo 7d	5moOct 2018 - Mar 2019
2025 selloff2025	-13.64%Apr 2025	1mo 6d	1mo 29d	3mo 5dMar 2025 - Jun 2025
2026 pullback2026	-8.25%Mar 2026	27d	1mo 12d	2mo 9dMar 2026 - May 2026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.

Loading charts...

Diversification

Diversification Metrics

Number of Effective Assets

The portfolio contains 19 assets, with an effective number of assets of 19.00, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.

Diversification Ratio

	1Y	3Y	5Y	All Time
Diversification Ratio	2.54	2.11	1.87	1.67

The portfolio has a diversification ratio of 1.67, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.

2025-08 Stock Rater test 2 correlation to the S&P 500 Index

2025-08 Stock Rater test 2 has a 0.72 correlation to S&P 500 Index over the trailing 12 months. This section compares each holding's correlation to the benchmark and to the portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.72
Correlation (3Y) Calculated over the trailing 3-year period	0.75
Correlation (5Y) Calculated over the trailing 5-year period	0.84
Correlation (All Time) Calculated using the full available price history since Mar 16, 2018	0.88

Benchmark Correlations

Correlation vs. S&P 500 Index. AMZN has the highest benchmark correlation at 0.67, while VZ has the lowest at 0.25.

0.25

0.28

0.34

0.35

0.36

0.36

0.42

0.48

0.49

0.50

0.55

0.58

0.60

0.61

0.62

0.63

0.66

0.67

AMZN

0.67

Portfolio Correlations

Correlation vs. 2025-08 Stock Rater test 2. MS has the highest portfolio correlation at 0.67, while VZ has the lowest at 0.38.

0.38

0.42

0.43

0.47

0.48

0.49

0.49

0.54

0.55

0.56

0.58

0.59

0.61

0.62

0.62

0.62

0.64

0.66

0.67

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

	ZS	VZ	NEE	MRK	SUI	CVS	ABBV	AMZN	ADBE	AMGN	RTX	ABT	TMO	LOW	BNS	CAT	JPM	GLW	MS
ZS	1.00	-0.03	0.10	0.04	0.19	0.05	0.10	0.50	0.56	0.12	0.12	0.25	0.31	0.25	0.17	0.16	0.14	0.25	0.24
VZ	-0.03	1.00	0.34	0.32	0.28	0.32	0.29	0.03	0.08	0.32	0.23	0.30	0.21	0.26	0.25	0.23	0.26	0.17	0.19
NEE	0.10	0.34	1.00	0.25	0.41	0.20	0.22	0.17	0.18	0.27	0.23	0.33	0.27	0.30	0.25	0.16	0.17	0.20	0.17
MRK	0.04	0.32	0.25	1.00	0.25	0.31	0.45	0.10	0.14	0.48	0.24	0.39	0.37	0.21	0.18	0.21	0.21	0.19	0.16
SUI	0.19	0.28	0.41	0.25	1.00	0.20	0.24	0.19	0.25	0.28	0.24	0.34	0.31	0.33	0.29	0.18	0.21	0.22	0.22
CVS	0.05	0.32	0.20	0.31	0.20	1.00	0.37	0.11	0.11	0.34	0.36	0.29	0.25	0.31	0.31	0.33	0.37	0.33	0.34
ABBV	0.10	0.29	0.22	0.45	0.24	0.37	1.00	0.14	0.20	0.51	0.28	0.40	0.34	0.28	0.25	0.28	0.27	0.26	0.24
AMZN	0.50	0.03	0.17	0.10	0.19	0.11	0.14	1.00	0.59	0.22	0.20	0.28	0.36	0.35	0.31	0.30	0.29	0.36	0.36
ADBE	0.56	0.08	0.18	0.14	0.25	0.11	0.20	0.59	1.00	0.26	0.22	0.39	0.44	0.39	0.27	0.24	0.24	0.31	0.31
AMGN	0.12	0.32	0.27	0.48	0.28	0.34	0.51	0.22	0.26	1.00	0.27	0.42	0.40	0.31	0.27	0.30	0.27	0.32	0.26
RTX	0.12	0.23	0.23	0.24	0.24	0.36	0.28	0.20	0.22	0.27	1.00	0.28	0.26	0.33	0.44	0.50	0.51	0.42	0.48
ABT	0.25	0.30	0.33	0.39	0.34	0.29	0.40	0.28	0.39	0.42	0.28	1.00	0.57	0.38	0.31	0.25	0.29	0.31	0.30
TMO	0.31	0.21	0.27	0.37	0.31	0.25	0.34	0.36	0.44	0.40	0.26	0.57	1.00	0.40	0.31	0.33	0.29	0.37	0.35
LOW	0.25	0.26	0.30	0.21	0.33	0.31	0.28	0.35	0.39	0.31	0.33	0.38	0.40	1.00	0.40	0.43	0.38	0.42	0.42
BNS	0.17	0.25	0.25	0.18	0.29	0.31	0.25	0.31	0.27	0.27	0.44	0.31	0.31	0.40	1.00	0.55	0.58	0.49	0.59
CAT	0.16	0.23	0.16	0.21	0.18	0.33	0.28	0.30	0.24	0.30	0.50	0.25	0.33	0.43	0.55	1.00	0.59	0.58	0.59
JPM	0.14	0.26	0.17	0.21	0.21	0.37	0.27	0.29	0.24	0.27	0.51	0.29	0.29	0.38	0.58	0.59	1.00	0.51	0.76
GLW	0.25	0.17	0.20	0.19	0.22	0.33	0.26	0.36	0.31	0.32	0.42	0.31	0.37	0.42	0.49	0.58	0.51	1.00	0.56
MS	0.24	0.19	0.17	0.16	0.22	0.34	0.24	0.36	0.31	0.26	0.48	0.30	0.35	0.42	0.59	0.59	0.76	0.56	1.00

The correlation results are calculated based on daily price changes starting from Mar 16, 2018

Diversification Analysis

Find what 2025-08 Stock Rater test 2 is missing

See which holdings overlap, where 2025-08 Stock Rater test 2 is concentrated, and which low-correlation assets could fill the gaps.

Analyze Diversification